Chemotherapy of haematological malignancies. Prognostic significance.
D000208:Acute Disease; D000903:Antibiotics, Antineoplastic; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy; D004358:Drug Therapy; D004359:Drug Therapy, Combination; D006027:Glycosides / Q000627:therapeutic use; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000401:mortality; D007951:Leukemia, Myeloid / Q000188:drug therapy; D008223:Lymphoma / Q000188:drug therapy; D008232:Lymphoproliferative Disorders / Q000188:drug therapy; D009196:Myeloproliferative Disorders / Q000188:drug therapy; D009279:Naphthacenes / Q000627:therapeutic use; D011087:Polycythemia Vera / Q000188:drug therapy; D011379:Prognosis
D000903:Antibiotics, Antineoplastic; D006027:Glycosides; D009279:Naphthacenes